6June - 2020TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comAs a result of rapid digitalisation in the pharmaceutical sector, one of the significant trends shaping the domain in 2019 was the majority of big sellers going off-patent. According to recent market research on bioanalytical testing services, the aim behind this surge in off-patent investments was to drive more investment in the field and replenish the technology trove among the bioanalytical services providers. The report also talked extensively about the increasing investment towards the research and development (R&D) department to enable better drug measurement services. Among the several markets that will be impacted by this trend, Asia Pacific (APAC) countries are anticipated to witness the most growth owing to the rise in the outsourcing of bioanalytical activities. With that said, the proliferation of several AI-enabled bioanalytical tools are addressing the most challenging areas of biologics and biosimilars, simultaneously aiming to provide objectivity to the scientific reviews and quality checks for regulated bioanalysis. Moreover, technologies such as machine vision and natural language processing are also automating several workflows within bioanalytics tools to dramatically reduce time taken in the data review process. Such innovations have also given scientists a new approach to whole-organism biomes in a more unique and more advanced manner like snapshots of transcriptomes, metabolomes, proteomes, and even microbiomes, which was previously difficult to achieve. Together with that, the attention has also fallen on fine-tuning the bioanalysis techniques to make it more tech-savvy and efficient, simultaneously.Highlighting these new developments, this edition of Pharma Tech Outlook features a list of prime vendors that are at the top of their game, working toward reinventingthe bioanalysis space, along with insightful articles from several thought leaders. We hope the valuable information and the innovative solutions from leading companies help you in effectively making informed decisions for your future endeavors.Let us know your thoughts!Reinventing Bioanalytical Services for the FutureCopyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.JUNE - 19 - 2020, Vol 06 - Issue 12 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405Jaxon JaseTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >